Medical Engineering Innovations, Inc.
- Industry
- Medical Devices and Equipment
- Founded Year
- 2005
- Headquarters
- Madison, Wisconsin, United States
- Employee Count
- 0
Key People
- Laura Jelle - Chief Executive Officer / Market Development
- Richard Schmidt - Chief Science Officer & Board Member
- Jim Jacoby - Director of Engineering
- Pamela Ziemlewicz - Director, Quality and Regulatory Affairs
- David Mahvi - Board Member
- James A. Will - Board Member
- Dieter Haemmerich - Board Member
- Dennis Beard - Board Member
Assessment
- Team
-
Aspect: First-time 10+ yrs
Summary: The leadership team comprises individuals with over a decade of experience in the medical device industry.
The presence of seasoned professionals in key roles suggests a strong foundation for strategic decision-making and operational execution.
- Clinical Need
-
Aspect: Strong
Summary: The company's focus on liver resection surgeries and localized cancer treatments addresses significant clinical needs.
By developing technologies that improve patient outcomes in liver surgeries and tumor ablation, the company is addressing pressing medical challenges.
- Competition
-
Aspect: Somewhat crowded
Summary: The market for surgical tools in cancer treatment is moderately competitive.
While there are existing players in the market, the company's unique technologies may provide a competitive edge.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing advanced surgical tools involves a moderate level of technical complexity.
The integration of proprietary software algorithms with enhanced blade electrode geometries requires careful engineering and validation.
- Patent
-
Aspect: Strong
Summary: The company holds patents for its radio frequency ablation systems.
Patents such as US11707322 and US11291501 provide legal protection for the company's innovations in ablation technology.
- Financing
-
Aspect: Medium
Summary: The company has secured funding through private equity and venture rounds.
Investments from Serra Ventures and gbeta indicate investor confidence, but further financing may be required to scale operations.
- Regulatory
-
Aspect: Pivotal Trial
Summary: The company is likely in the pivotal trial phase for its products.
Successful completion of pivotal trials is essential for obtaining FDA clearance and subsequent market entry.
Opportunity Rollup
- Odds of Success
- 3.5
- Peak Market Share
- 4.85
- Segment CAGR
- 4.0%
- Market Segment
- General Surgery Devices
- Market Sub Segment
- Surgical Ablation Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.24 |
| 2 | 0.73 |
| 3 | 1.70 |
| 4 | 3.40 |
| 5 | 4.85 |
Key Takeaway
Medical Engineering Innovations, Inc. is well-positioned in the surgical ablation market, leveraging strong patents and experienced leadership to address significant clinical needs in liver cancer treatment.